| PRODUCT | SUBMIT DATE | STATUS | DMF HOLDER | dmf_Primary_Key | dmf_Number | TYPE |
|---|---|---|---|---|---|---|
| APIXABAN | 31/03/2022 | Active | OPTIMUS DRUGS PRIVATE LTD | 1 | 36.651 | II |
| MIGALASTAT HYDROCHLORIDE | 31/03/2022 | Active | LUPIN LTD | 2 | 36.729 | II |
| REVEFENACIN | 31/03/2022 | Active | MSN LABORATORIES PRIVATE LTD | 3 | 36.767 | II |
| MIRABEGRON | 31/03/2022 | Active | CIPLA LTD | 4 | 36.778 | II |
| NITROFURANTOIN MONOHYDRATE USP | 31/03/2022 | Active | ALEMBIC PHARMACEUTICALS LTD | 5 | 36.784 | II |
| LAROTRECTINIB SULFATE | 31/03/2022 | Active | ALEMBIC PHARMACEUTICALS LTD | 6 | 36.785 | II |
| MAXNUCLEASE | 31/03/2022 | Active | KACTUS BIOSYSTEMS CO LTD | 7 | 36.799 | II |
| OLMESARTAN MEDOXOMIL USP | 31/03/2022 | Active | GRANULES INDIA LTD | 8 | 36.865 | II |
| SIPONIMOD HEMIFUMARATE | 31/03/2022 | Active | DR REDDYS LABORATORIES LTD | 9 | 36.927 | II |
| EMPAGLIFLOZIN (PRODUCT CODE: EGF8) | 31/03/2022 | Active | DR REDDYS LABORATORIES LTD | 10 | 36.928 | II |
| PRODUCT | SUBMIT DATE | STATUS | DMF HOLDER |